Search by Drug Name or NDC

    NDC 00575-6200-30 Proglycem 50 mg/mL Details

    Proglycem 50 mg/mL

    Proglycem is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is DIAZOXIDE.

    Product Information

    NDC 00575-6200
    Product ID 0575-6200_feeca3aa-0bb3-4873-8887-e1c53accf956
    Associated GPIs 27300020001810
    GCN Sequence Number 000298
    GCN Sequence Number Description diazoxide ORAL SUSP 50 MG/ML ORAL
    HIC3 M4G
    HIC3 Description AGENTS TO TREAT HYPOGLYCEMIA (HYPERGLYCEMICS)
    GCN 01280
    HICL Sequence Number 000092
    HICL Sequence Number Description DIAZOXIDE
    Brand/Generic Brand
    Proprietary Name Proglycem
    Proprietary Name Suffix n/a
    Non-Proprietary Name diazoxide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 50
    Active Ingredient Units mg/mL
    Substance Name DIAZOXIDE
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA017453
    Listing Certified Through 2024-12-31

    Package

    NDC 00575-6200-30 (00575620030)

    NDC Package Code 0575-6200-30
    Billing NDC 00575620030
    Package 1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) / 30 mL in 1 BOTTLE, DROPPER
    Marketing Start Date 1990-09-30
    NDC Exclude Flag N
    Pricing Information N/A